AGI-14100 is a novel orally available mIDH1 inhibitor. Preclinical trials of AGI-14100 for the treatment of primary human myeloid leukemia therapy have been underway since 2013.
MedKoo Cat#: 591800
Name: AGI-14100
CAS#: 1448346-43-7
Chemical Formula: C29H22ClF4N5O3
Exact Mass: 599.1347
Molecular Weight: 599.97
Elemental Analysis: C, 58.06; H, 3.70; Cl, 5.91; F, 12.67; N, 11.67; O, 8.00
The following data is based on the product molecular weight 599.97 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |